AN2 THERAPEUTICS INC's ticker is and the CUSIP is 037326105. A total of 38 filers reported holding AN2 THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $44,783 | -87.5% | 2,785 | -93.4% | 0.00% | – |
| Q2 2023 | $359,058 | -20.1% | 42,242 | -7.2% | 0.00% | – |
| Q1 2023 | $449,401 | +14.2% | 45,532 | +10.2% | 0.00% | – |
| Q4 2022 | $393,637 | -43.7% | 41,305 | +2.7% | 0.00% | – |
| Q3 2022 | $699,000 | +123.3% | 40,233 | -0.2% | 0.00% | – |
| Q2 2022 | $313,000 | +2135.7% | 40,331 | +4457.2% | 0.00% | – |
| Q1 2022 | $14,000 | – | 885 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 2,678,209 | $43,065,600 | 6.34% |
| Octagon Capital Advisors LP | 867,575 | $13,950,606 | 2.14% |
| RA Capital Management | 5,551,295 | $89,264,824 | 1.76% |
| Frazier Life Sciences Management, L.P. | 1,388,889 | $22,333,335 | 1.48% |
| Avidity Partners Management LP | 1,089,400 | $17,517,552 | 0.70% |
| BVF INC/IL | 1,563,963 | $25,148,525 | 0.68% |
| Monashee Investment Management LLC | 99,495 | $1,599,880 | 0.67% |
| Nantahala Capital Management | 356,789 | $5,737,167 | 0.49% |
| ACUTA CAPITAL PARTNERS, LLC | 13,300 | $213,864 | 0.14% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 905,556 | $14,561,340 | 0.03% |